US Patent Issued to SHIONOGI & Co. on March 24 for "Nucleic acid drug targeting MURF1" (Japanese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,584,132, issued on March 24, was assigned to SHIONOGI & Co. LTD. (Osaka, Japan).

"Nucleic acid drug targeting MURF1" was invented by Takahiro Fujiwara (Osaka, Japan), Kazuyoshi Tomita (Osaka, Japan), Kunitaka Nashiki (Osaka, Japan), Ayumi Nagasawa (Osaka, Japan), Ryo Yoshimoto (Osaka, Japan) and Takahito Ito (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "It was found that nucleic acids for the specific targeting sequences or nucleic acids having the specific sequences have superior suppression activities of MURF1 expression. Pharmaceutical compositions including the nucleic acids as active ingredient are useful for treating or preventing ...